2.Prevention and treatment of chemotherapy related fatty liver disease and hepatitis B virus reactivation in breast cancer patients during chemotherapy
Yutuan WU ; Lingquan KONG ; Hongyuan LI ; Guosheng REN ; Kainan WU
Chinese Journal of Endocrine Surgery 2017;11(5):426-429
Chemotherapy plays an important role in the comprehensive treatment of breast cancer,and chemotherapy related fatty liver disease (CRFLD) and hepatitis B virus (HBV) reactivation were still ignored at present.It would cause great influence on the patient's outcome.Preventive measures on them will be discussed in this paper.
3.To strengthen the diagnosis and treatment of male breast cancer in China
Lingquan KONG ; Yutuan WU ; Hongyuan LI ; Guosheng REN ; Kainan WU
Chinese Journal of Endocrine Surgery 2018;12(2):89-91
Male breast cancer is a rare disease with an incidence of about 1% of breast cancers in USA,and about 1.4% in China.Male breast cancer accounts for 1.9% to 6.5%(with the mean value of 2.9%) of breast cancers in southwest of China.In China,male breast cancer is usually with poor prognosis caused by delayed diagnosis and treatment,because of being ignored by the community.It is important to strengthen the popular science propaganda,diagnosis and treatment of male breast cancer in China.